Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
5.01
0.00 (0.00%)
Oct 29, 2025, 4:00 PM EDT - Market open
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $37.54 million as of October 30, 2025. Its market cap has decreased by -2.85% in one year.
Market Cap
37.54M
Enterprise Value
17.01M
1-Year Change
-2.85%
Ranking
Category
Stock Price
$5.01
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $37.54M, a decrease of -48.47%. That is a compound annual growth rate of -15.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 37.54M | 15.22% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.33B |
| Johnson & Johnson | 449.57B |
| AbbVie | 397.72B |
| UnitedHealth Group | 321.75B |
| AstraZeneca | 257.84B |
| Novartis AG | 237.42B |
| Novo Nordisk | 232.34B |
| Abbott Laboratories | 216.57B |